|
FAM50A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.726299999949E-06 |
| Normal-vs-Stage3 |
8.6512999986077E-08 |
| Normal-vs-Stage4 |
1.175750E-03 |
| Stage1-vs-Stage2 |
3.107400E-01 |
| Stage1-vs-Stage3 |
7.139000E-01 |
| Stage1-vs-Stage4 |
4.066200E-01 |
| Stage2-vs-Stage3 |
2.954600E-01 |
| Stage2-vs-Stage4 |
7.320800E-01 |
| Stage3-vs-Stage4 |
2.738600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.33689767326473E-11 |
| Normal-vs-Asian |
4.761600E-03 |
| Caucasian-vs-AfricanAmerican |
8.406400E-01 |
| Caucasian-vs-Asian |
1.961390E-01 |
| AfricanAmerican-vs-Asian |
2.410600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.08568709578094E-12 |
| Male-vs-Female |
3.701800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.64819993395827E-10 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
1.31339383813156E-13 |
| Normal-vs-Extreme_Obese |
1.615920E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.676200E-01 |
| Normal_Weight-vs-Obese |
2.213400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.933200E-01 |
| Extreme_Weight-vs-Obese |
4.813000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.397800E-01 |
| Obese-vs-Extreme_Obese |
7.936200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.09280000049061E-07 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.135510E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.512000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.798200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.594300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.234800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.675000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.864800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
6.67049970815015E-10 |
| Normal-VS-KIRP CIMP |
2.3257999999915E-05 |
| Normal-VS-Unclassified PRCC |
5.44010000047557E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.267600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.651400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.711800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.952820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.955800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.337600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60870206045161E-11 |
| Normal-vs-N1 |
2.24620000377485E-08 |
| Normal-vs-N2 |
6.535800E-01 |
| N0-vs-N1 |
4.430200E-01 |
| N0-vs-N2 |
6.182100E-02 |
| N1-vs-N2 |
4.001700E-02 |
|
|
